Insider Trading activities of Evofem Biosciences, Inc. insiders.

Monthly summaries of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Evofem Biosciences, Inc. since 2005 are illustrated in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Evofem Biosciences, Inc. since year 2005. Table 2 shows the detailed insider transactions of Evofem Biosciences, Inc. since 2005. The reporting company's ticker symbol is EVFM. The reporting company's CIK number is 1618835.
The total value of stock buying since 2005 is $13,906,477.
The total value of stock sales since 2005 is $4,165,521.
The total value of stock option exercises since 2005 is $2,366,122.


Table 1. Monthly summaries of insider stock purchases, sales, and option exercises for Evofem Biosciences, Inc. (EVFM).
Trading Period Insider Buying Insider Sales Option Exercises
year-month Shares Value Shares Value Shares Value
2018-05 2,127,659 $9,978,720 0 $0 0 $0
2016-06 0 $0 0 $0 16,393 $18,524
2015-12 0 $0 1,328,851 $1,965,833 0 $0
2015-11 0 $0 6,098 $50,619 6,098 $50,619
2015-09 0 $0 4,000 $46,185 4,000 $5,002
2015-08 0 $0 1,000 $12,880 1,000 $1,220
2015-06 0 $0 0 $0 10,848 $13,234
2015-03 1,000 $7,757 0 $0 0 $0
2014-11 280,000 $3,920,000 149,286 $2,090,004 266,689 $2,277,523

Table 2. Detailed insider stock purchases, sales, and option exercises of Evofem Biosciences, Inc. insiders (EVFM)
  Trade Date   Insider Name Trade Type     Shares       Price ($)   Value ($)
2018-05-22 Invesco Ltd. (10% Owner) Buy 2,127,659 4.69 9,978,720
2016-06-21 Demski Martha J (Director) Option Ex 16,393 1.13 18,524
2015-12-30 Nohra Guy P (Other) Sale 250,000 1.44 360,000
2015-12-29 Nohra Guy P (Other) Sale 493,654 1.53 755,290
2015-12-28 Nohra Guy P (Other) Sale 54,333 1.59 86,389
2015-12-17 Knudson Susan A. (Chief Financial Officer) Sale 1,005 1.26 1,266
2015-12-17 Locke Kenneth W (Chief Scientific Officer) Sale 598 1.26 753
2015-12-15 Nohra Guy P (10% Owner) Sale 529,261 1.44 762,135
2015-11-18 Locke Kenneth W (Chief Scientific Officer) Sale 6,098 8.30 50,619
2015-11-18 Locke Kenneth W (Chief Scientific Officer) Option Ex 6,098 8.30 50,619
2015-09-18 Kemmerer Christopher (VP, Pharma Dev & Manufacturing) Sale 1,000 12.20 12,195
2015-09-18 Kemmerer Christopher (VP, Pharma Dev & Manufacturing) Option Ex 1,000 1.34 1,342
2015-09-01 Knudson Susan A. (Chief Financial Officer) Sale 3,000 11.33 33,990
2015-09-01 Knudson Susan A. (Chief Financial Officer) Option Ex 3,000 1.22 3,660
2015-08-07 Kemmerer Christopher (VP, Pharma Dev & Manufacturing) Sale 1,000 12.88 12,880
2015-08-07 Kemmerer Christopher (VP, Pharma Dev & Manufacturing) Option Ex 1,000 1.22 1,220
2015-06-12 Kemmerer Christopher (VP, Pharma Dev & Manufacturing) Option Ex 10,848 1.22 13,234
2015-03-19 Mahaffey George W (President and CEO) Buy 1,000 7.76 7,757
2014-11-25 Gorbachev Maxim (Director) Buy 70,000 14.00 980,000
2014-11-25 Rusnanomedinvest Llc (10% Owner) Buy 70,000 14.00 980,000
2014-11-25 Halak Brian K (10% Owner) Buy 70,000 14.00 980,000
2014-11-25 Halak Brian K (10% Owner) Option Ex 262,292 8.54 2,239,973
2014-11-25 Nohra Guy P (10% Owner) Buy 70,000 14.00 980,000
2014-11-25 Nohra Guy P (10% Owner) Sale 149,286 14.00 2,090,004

Insider trading activities including stock purchases, stock sales, and option exercises of EVFM listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Evofem Biosciences, Inc. (symbol EVFM, CIK number 1618835) see the Securities and Exchange Commission (SEC) website.